A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IberDd)VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVd) IN SUBJECTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) (EXCALIBER-RRMM) - Project - Authors - KSSG Research Database

Project

A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY COMPARING IBERDOMIDE, DARATUMUMAB AND DEXAMETHASONE (IberDd)VERSUS DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVd) IN SUBJECTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) (EXCALIBER-RRMM)

Ongoing - recruitment active · 2022 until 2030

Lehmann Thomas, Sakic Miranda, Müller Fiona

Lehmann, Thomas

Medizinische Onkologie und Hämatologie · Dept. I

Sakic, Miranda

Medizinische Onkologie und Hämatologie · Dept. I

Müller, Fiona

Medizinische Onkologie und Hämatologie · Dept. I